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Membrane ﬂuidityAnnexin A2 (AnxA2) is a phospholipid binding protein that has been implicated inmanymembrane-related
cellular functions. AnxA2 is able to bind different acidic phospholipids such as phosphatidylserine (PS) and
phosphatidylinositol-4,5-bisphosphate (PI2P). This binding ismediated by Ca2+-dependent and Ca2+-independent
mechanisms. The speciﬁc functions of annexin A2 related to these two phospholipids and the molecular mecha-
nisms involved in their interaction remain obscure. Herein we studied the inﬂuence of lipid composition on the
Ca2+-dependency of AnxA2-mediatedmembrane bridging andonmembraneﬂuidity.Membranemodels of tendif-
ferent lipid compositions and detergent-resistant membranes from two cellular sources were investigated. The re-
sults show that theAnxA2-mediatedmembrane bridging requires 3 to 50 times less calcium for PS-membranes than
for PI2P-membranes. Membrane ﬂuidity was measured by the ratiometric ﬂuorescence parameter generalized po-
larization method with two ﬂuorescent probes. Compared to controls containing low phospholipid ligand, AnxA2
was found to reduce the membrane ﬂuidity of PI2P-membranes twice as much as the PS-membranes in the pres-
ence of calcium. On the contrary, at mild acidic pH in the absence of calcium AnxA2 reduces the ﬂuidity of the
PS-membranes more than the PI2P-membranes. The presence of cholesterol on the bilayer reduced the AnxA2 ca-
pacity to reduce membrane ﬂuidity. The presented data shed light on the speciﬁc roles of PI2P, PS and cholesterol
present on membranes related to the action of annexin A2 as a membrane bridging molecule during exocytosis
and endocytosis events and as a plasma membrane domain phospholipid packing regulator.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The characterization of lipid diversity and the distribution of speciﬁc
lipids in cell organelles and plasmamembrane domains are becoming es-
sential for the ﬁne understanding of membrane cell biology (for a review
see [1]). Annexins (Anxs) are a family of calcium and phospholipid bind-
ing proteins involved in different membrane-related cellular functions
[2,3]. Anxs are found in different organelles and speciﬁc regions of the
plasma membrane and show different afﬁnities for cellular membranes
with speciﬁc calcium requirements [4,5]. Their Ca2+-sensitivity for
binding to different phospholipids has been studied in vitro revealing
that each Anx possesses speciﬁc preferences for different phospholipids.
For example, AnxA5 Ca2+-sensitivity was reported to be in the range of
0.16 to 0.75 mM for the following phospholipids in the orderstant membranes; LUV, large
PE, phosphatidylethanolamine;
tidylserine
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l rights reserved.dioleoylphosphatidylglicerolbdioleoylphosphatidylserinebphosphatidy-
linositol (PI)bphosphatidic acid (PA) [6]. For AnxA4, the Ca2+-sensitivity
was in the range of 40 to 120 μM for PAbphosphatidylserine
(PS)bphosphatidylglicerol (PG)bphosphatidylinositol-4,5-bisphosphate
(PI2P)bPI in this order [7]. Moreover, the individual calcium binding
sites of the four annexin repeats can show characteristic afﬁnities for
the different phospholipids. For example, the fourth repeat of AnxA4
was reported to be involved in PS and PI binding but not in PGbinding [8].
Phospholipid organization and distribution can be modiﬁed by pro-
tein binding. Phospholipid clustering by Anxs has been reported in
vitro and in vivo. AnxA2 is able to induce PS and PI2P segregation and
clustering in vitro [9,10]. Anxs A4 and A6 were also shown to induce
clustering of their binding phospholipids PG and PA respectively
[11,12]. Moreover, the speed of PA clustering depended on the presence
of phosphatidylcholine (PC) and phosphatidylethanolamine (PE) [13]
indicating that lipids not directly bound to the protein are able to mod-
ulate protein-membrane interactions. Several experiments with cells
suggested that the annexin family of proteins is responsible for
Ca2+-dependent lipid segregation in muscle cells [14] and that AnxA2
is involved in microdomain regulation of exocytic sites [15]. Cholesterol
plays also an important role in Annexins functions by modulating the
binding to negatively charged phospholipids [16–18] (for a review see
Table 1
Lipid composition of large unilamellar vesicles (LUV).
LUV Lipid (weight %)
PCa PS or PI2Pb PE Cholesterol
LUV1 75 25 0 0
LUV2 50 25 0 25
LUV3 20 20 35 25
LUV4 25 15 60 0
LUV5 17 12 52 19
a Phosphatidylcholine.
b Depending on the experiment, the anionic phospholipid ligand for AnxA2 was
phosphatidylserine (PS) or phosphatidylinositol-4,5-bisphosphate (PI2P).
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to biological and artiﬁcial membranes [20]. Finally, the binding and cel-
lular distribution of AnxA6 in Ca2+-dependent and independent pools
was shown to be modulated by cholesterol [21].
Several experiments demonstrated that cholesterol regulates the
Ca2+-dependent and independent binding of AnxA2 to membranes
in vitro [22] and in vivo [17,23]. Moreover, this Ca2+-independent
binding to membranes seemed to be induced by acidic pH as demon-
strated in vitro [24,25] and in vivo [26]. The role of PS in AnxA2 mem-
brane binding is well known, but the role of PI2P in actin cytoskeleton
membrane-related processes [27–29], in macropinocytosis [30] and
exocytosis [31] has also been reported leading to the possibility that
AnxA2 plays different cellular roles in membranes depending on
their enrichment in PS or PI2P.
In spite of the fact that many studies on lipid-AnxA2 interaction
have been performed, a simple explanation of the annexin A2 effects
on themembranes including different parameters such as calcium con-
centration, pH, lipid composition and the physicochemical properties of
the membrane is lacking. In this study we performed comparative ex-
periments with large unilamellar vesicles (LUV) of different composi-
tion focusing on the relative importance of PS, PI2P and cholesterol on
AnxA2-membrane interactions. The results show thatAnxA2 interaction
with membranes and its effects depend on lipid organization. The
Ca2+-sensitivity of AnxA2 is higher for PS-rich than for PI2P-rich
membranes but it exerts a stronger reduction of membrane ﬂuidity
in PI2P-rich membranes. The membrane ﬂuidity changes were also
observed in cellular detergent-resistant membranes.
2. Material and methods
2.1. Reagents
Egg yolk L-α-phosphatidylcholine (PC), egg yolk L-α-
phosphatidylethanolamine (PE), brain L-α-glycerophosphatidyl-L-
serine (PS) and cholesterol were purchased from Sigma-Aldrich. Brain
L-α-phosphatidylinositol-4,5-bisphosphate (PI2P) was from Avanti
polar lipids. Laurdan was from Molecular Probes. Di-4-ANNEPDHQ
was obtained from Dr Leslie M. Loew (Connecticut, USA). Recombinant
human AnxA2 and human S100A10 were puriﬁed as previously de-
scribed [32]. The tetrameric complex (AnxA2T; (AnxA2-S100A10)2)
was obtained by mixing equimolar quantities of AnxA2 and S100A10.
The rabbit polyclonal anti-AnxA2 was produced in our laboratory. The
rabbit polyclonal anti-Caveolin1 was from Santa Cruz Biotechnology.
The anti-S100A10 and the anti-E-cadherinwere fromTransduction Lab-
oratories. The goat anti-rabbit IgG-peroxidase and the secondary ﬂuo-
rescent (FITC, CY3 and CY5) conjugated anti-rabbit or anti-mouse
antibodies were from Jackson ImmunoResearch.
2.2. Large unilamellar vesicles
Multilamellar vesicles (MLVs) were obtained by dissolving the ap-
propriate amounts of lipids (see Table 1) in a mixture of chloroform
and methanol, 2/1 (v/v), followed by solvent evaporation under nitro-
gen. For ﬂuorescence experiments, laurdan was added at 0.1% weight.
Lipid ﬁlms were hydrated with buffer A (40 mM Hepes pH 7, 30 mM
KCl, 1 mM EGTA) and vortexed extensively. Large unilamellar vesicles
(LUV) were prepared by extrusion of MLVs through a polycarbonate ﬁl-
ter (pore diameter 100 nm) as previously described [33].
2.3. Membrane bridging
LUVs aggregation by annexin A2-mediated membrane bridging was
monitored by turbidimetry at 340 nm with a Cary spectrophotometer
(Varian) as described [34]. The temperaturewas regulatedwith a Peltier
device and controlled by a thermocouple. Free-Ca2+ concentration was
controlled in buffer A as described [35]. The Ca2+ concentrations areexpressed as pCa=−Log[Ca2+]. 5 μg of monomeric or tetrameric
AnxA2 were added to a ﬁnal 250 μl buffer containing 5 μg of LUVs
(20 μg ml−1 for both protein and phospholipids). In these conditions,
the lipid/protein molar ratio for interaction is 25. Considering that an
annexin protein can cover between 26 and 31 nm2 and a phospholipid
a surface of 0.6 nm2 [6,36,37], there is enough protein to cover the en-
tire surface of the vesicles. Moreover, in our pCa 3.3 and pH 4.5 experi-
mental conditions there is 100% protein binding and vesicle aggregation
[16,22,24,32,34]. In conclusion, the experiments are near saturation of
bound protein and therefore comparable. After protein addition the ab-
sorbancewas followed for 7 min. At this timemembrane aggregation is
very close to the plateau. Graphics and curve ﬁtting were performed
with Graphpad Prism software.
2.4. Cell culture and immunoﬂuorescence
Madin Darby Canine kidney (MDCK) cells were grown in Dulbecco's
modiﬁed Eagle's medium (DMEM; Life Technologies, France) supple-
mentedwith 10%heat-inactivated fetal bovine serum(Life Technologies),
penicillin (0.1 i.u./ml) and streptomycin (100 mg/ml). Cells were grown
at 37 °C in a 5% CO2/air atmosphere. To obtain differentiated epithelial
MDCK cells, the cultures were recovered 2 days after conﬂuence. To ob-
tain undifferentiated cells we used the Ca2+ switch strategy [38]. Brieﬂy
conﬂuent MDCK cultures were incubated in a Ca2+-free medium for
two days. This medium was prepared with Ca2+-free DMEM and serum
dialyzed against PBS. For immunoﬂuorescence the cells were cultured
on glass cover-slips in 24 well plates. The cells were washed twice with
PBS, and ﬁxed with 3.7% paraformaldehyde in PBS for 15 min at room
temperature. Then they were washed three times with PBS, NH4Cl
50 mM and post-ﬁxed and permeabilized with cold methanol (−20 °C)
for 1 min and washed three times as before. Fixed cells were saturated
with PBS, NH4Cl 50 mM, BSA 1% for 20 min at room temperature. The
ﬁrst antibody was added at the right dilution during 1.5 hours at room
temperature followed by threewashes in saturation solution. The second-
ary antibody was incubated and washed as the primary antibody. Finally,
the cover-slips were washed in water, dried and mounted in Mowiol. All
the ﬂuorescence confocal images were acquired with a TCS SP2 laser-
scanning spectral system (Leica, Wetzlar, Germany) attached to a Leica
DMR inverted microscope (Platform Imagerie cellulaire et tissulaire,
IFR65) at the speciﬁc excitation wavelengths and appropriate emission
channels for each ﬂuorophore.
2.5. Detergent-resistant membranes from nondifferentiated and differen-
tiated epithelial cells
TheTritonX-100detergent-resistantmembranes(DRM)preparationwas
performed at 4 °C. Cell cultures (from 75 mm ﬂasks)werewashedwith PBS
and lysed in buffer A containing Triton X-100 1% (w/v) and a protease
inhibitor cocktail. The cell suspension was passed 10 times through
G23 and G26 needles. The cell extract was diluted with 80% sucrose so-
lution in buffer A to obtain a ﬁnal 40% sucrose suspension (4 ml) that
was loaded in a SW41 Beckman tube. 4 ml of 35% sucrose solution
and 3.5 ml of 5% sucrose solution were sequentially added to the tube
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38000 rpm for 18 h at 4 °C. After centrifugation, twelve 1 ml frac-
tions were recovered. Caveolin1 and AnxA2 contents were analyzed
by Western blot on PVDF membranes by standard procedures using
the ECL method (Amersham).2.6. Fluorescence recording
Fluorescence measurements were performed with a Cary ﬂuorime-
ter (Varian) as previously described [39]. The protein and LUV concen-
tration and the temperature regulationwere as described in Section 2.3.
The excitation and emission band-pass were set at 5 nm. For laurdan
ﬂuorescence, the emission spectra were recorded from 400 to 650 nm
using 365 nm excitation. Sequential spectra were recorded as follows:
ﬁrst, free LUVs in buffer A, then the LUVs in the presence of calcium
(0.5 mM), and ﬁnally 10 min after AnxA2 addition. For experiments
at pH 4.5, the free-Ca2+ buffer B (40 mM acetate pH 4.5, 30 mM KCl,
1 mM EGTA) was used. The excitation generalized polarization (GP)
for laurdan was calculated as GP=(I440− I490)/(I440+I490), where I440
and I490 are the ﬂuorescence intensities at the maximum emission
wavelength in the ordered (440 nm) and disordered (490 nm) phases
[40]. For DRMs, the probe di-4-ANNEPDHQ was used at 1 μM. This
probe such as laurdan, is able to monitor membrane ﬂuidity [41].
Ca2+ was added to 200 μl of DRMs for a ﬁnal 500 μM concentration.
Then, 10 μg of AnxA2 were added and incubated for 15 min. Finally,
to measure reversibility, EGTA was added (2 mM) and incubated for
30 min. before spectrum recording. The sequential emission spectra
were recorded from 500 to 750 nm using 485 nm excitation and the
wavelengths used for GP calculation were 570 and 630 nm for the or-
dered and disordered phases respectively. The statistical signiﬁcanceFig. 1. PS-LUV bridging by Annexin A2 as a function of calcium. Vesicle aggregation in perce
AnxA2 at 23 °C (c) and 37 °C (d). LUV composition is shown in Table 1. PS-LUV1 (■ dash d
(□ dotted line) and PS-LUV5 (○ continuous line). The calcium concentration for half maxi
in Tables 2 and 3.of the GP differences in Fig. 3 was assessed by ANOVA with GraphPad
Prism. *Pb0.05, **Pb0.01, ***Pb0.001.
3. Results
3.1. Ca2+-dependency for membrane bridging by AnxA2 depends on lipid
composition
In order to study the role of lipid composition on the Ca2+-
dependency of AnxA2 for membrane bridging, we compared large
unilamellar vesicles (LUV) containing phosphatidylserine (PS) as the
AnxA2 ligand phospholipid and different quantities of cholesterol, phos-
phatidylcholine and phosphatidylethanolamine (PE) (Table 1). Brieﬂy,
PS-LUV1 are rich in PS, PS-LUV2 are rich in PS and cholesterol, PS-LUV3
contain PS, PE and cholesterol in similar quantities, PS-LUV4 are rich in
PEmimicking the inner leaﬂet of the plasmamembrane without choles-
terol and PS-LUV5 mimic the inner leaﬂet with cholesterol. Fig. 1
shows that the Ca2+-dependency for membrane bridging by AnxA2
in its monomeric and tetrameric (complexed to the S100A10 dimer)
forms at 23 and 37 °C depends on the phospholipid composition.
For the monomeric AnxA2, the higher Ca2_sensitivity was observed
for the PS-LUV3 at 23 and 37 °C (see Table 2). The half maximal
aggregation was observed at pCa close to 5.8 (1.6 μM free-Ca2+).
PS-LUV1 presented the lower Ca2+-sensitivity with a pCa close to 4.4
(40 μM free-Ca2+) at both temperatures. For the other PS-LUVs, the
values were placed in between these calcium concentrations range. The
Ca2+-sensitivity did not correlate with the quantity of any phospholipid
in the membranes. PS-LUV3 contains less PS than PS-LUV1 but more
than PS-LUV4 or 5 (see Table 1). Inversely, PS-LUV3 containsmore PE
than PS-LUV1 and 2 but less than PS-LUV4 or 5. At 37 °C, the cholesterol
content does not explain the difference in calcium sensitivity becausent of maximal OD for monomeric AnxA2 at 23 °C (a) and 37 °C (b), and for tetrameric
ouble dotted line), PS-LUV2 (● dash dotted line), PS-LUV3 (▲ dashed line), PS-LUV4
mal aggregation (EC50 as pCa) and the number of experiments performed are shown
Table 2
Calcium concentration for half maximal membrane bridging (EC50) by monomeric AnxA2 (pCa).a
PS containing LUV
PS-LUV1 PS-LUV2 PS-LUV3 PS-LUV4 PS-LUV5
AnxA2 23 °C 4.37±0.09 (8) 5.28±0.05 (6) 5.81±0.03 (8) 4.78±0.14 (9) 5.26±0.28 (9)
AnxA2 37 °C 4.04±0.04 (5) 5.04±0.07 (6) 5.70±0.04 (5) 5.38±0.08 (7) 5.19±0.06 (6)
PI2P containing LUV
PI2P-LUV1 PI2P-LUV2 PI2P-LUV3 PI2P-LUV4 PI2P-LUV5
AnxA2 23 °C 3.72±0.53 (5) 4.57 (2) 4.14±0.11 (4) 5.07±1.12 (5) 5.33±0.07 (4)
AnxA2 37 °C nd nd 4.15 (2) 5.30±0.07 (3) 5.48±0.03 (3)
nd: not determined.
a The values are expressed in pCa±Std. error (N).
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aggregation very different at 37 °C (4 and 5.4 respectively), and PS-
LUV2 and 3 with the same cholesterol content showed also a quite
different pCa for half maximal aggregation (5 and 5.7 respectively).
However, at 23 °C, the Ca2+-sensitivity seemed to correlate with
the cholesterol content showing lower Ca2+ concentration to bridge
the PS-LUVs with cholesterol (Tables 1 and 2).
For the tetrameric AnxA2, theCa2+-sensitivity formembranebridging
at both temperatures was in the order: PS-LUV3>PS-LUV2>PS-LUV1>
PS-LUV4>PS-LUV5 (Fig. 1 and Table 3). As for the monomer, the
Ca2+-sensitivity does not correlate with any particular lipid. PS-LUV3, 4
and 5 contain PE, PS-LUV3, 2 and 5 contain cholesterol and the strongest
quantity of the ligand phospholipid (PS) is in PS-LUV1 and 2. Overall,
these results show that for both forms of the protein, therewas no simple
correlation of membrane bridging efﬁciency (Ca2+ concentration for half
maximal effect) with the phospholipid composition.
Considering that themost important differences in Ca2+-dependency
formembranebridgingwere observedwith themonomeric AnxA2, in the
next experiments we compared only themonomeric AnxA2 bridging
capacity on LUVs containing phosphatidylinositol-4,5-bisphosphate
(PI2P-LUVs), the second phospholipid described to play an important
role in AnxA2 binding to cell membranes. Fig. 2 shows the Ca2+-
dependency for aggregation of PI2P-LUVs at 23 and 37 °C. The analysis
of the Ca2+-sensitivity for aggregation revealed that, contrary to the
PS-LUVs, the PI2P-LUVs 2 and 3 with high cholesterol content need
more calcium to aggregate themembranes. The stronger Ca2+-sensitivity
was observed for the PI2P-LUVswith higher PE content and paradoxically
with the lower PI2P content (Table 2 and Fig. 2) suggesting that PE facil-
itates AnxA2 binding to PI2P.
The comparison of the AnxA2 Ca2+-dependency for membrane
bridging of PS versus PI2P-LUVs revealed different behavior for each
phospholipid. The pCa for half maximal aggregation for PS-LUV5 and
PI2P-LUV5 at both temperatures were about 5.2 and 5.4 respectively.
This difference can be considered as not signiﬁcant. However, the pCa
for PS-LUV3 was about 5.8, a value completely different than that for
PI2P-LUV3 (4.1 at both temperatures). The pCa values for LUV2 at
23 °C showed also higher Ca2+-sensitivity for PS than for PI2P con-
taining LUVs (5.2 and 4.5 respectively).Table 3
Calcium concentration for half maximal membrane bridging (EC50) by tetrameric
AnxA2 (pCa).a
PS containing LUV
PS-LUV1 PS-LUV2 PS-LUV3 PS-LUV4 PS-LUV5
AnxA2T
23 °C
6.20±0.04
(6)
6.50±0.07
(4)
6.77±0.04
(4)
6.19±0.03
(4)
6.01±0.06
(5)
AnxA2T
37 °C
6.28±0.03
(4)
6.59±0.03
(4)
6.72±0.04
(4)
6.14±0.03
(5)
6.05±0.03
(6)
nd: not determined.
a The values are expressed in pCa±Std. error (N).These results show that the Ca2+-sensitivity for AnxA2-mediated
membrane bridging does not follow a simple rule based in the ligand
phospholipid quantity, and suggest strongly that the determinant fac-
tor of Ca2+-sensitivity for AnxA2-mediated membrane bridging is the
organization of lipids in different membrane domains.3.2. Annexin A2 modulates membrane ﬂuidity
The binding of AnxA2 to speciﬁc phospholipidswould be expected to
induce changes inmembrane organization and properties. Therefore, we
investigated whether AnxA2 modiﬁed membrane ﬂuidity by using the
ﬂuorescent probe laurdan. This probe shows a spectrum centered at
440 nm in membranes in the gel phase (rigid) and centered at 490 nm
in liquid disordered (ﬂuid) phase. A spectral shift toward the blueFig. 2. PI2P-LUV bridging by Annexin A2 as a function of calcium. Vesicle aggregation in
percent of maximal OD for AnxA2 at 23 °C (a) and 37 °C (b). The LUV composition is in
Table 1. PI2P-LUV1 (■ dash double dotted line), PI2P-LUV2 (● dash dotted line),
PI2P-LUV3 (▲ dashed line), PI2P-LUV4 (□ dotted line) and PI2P-LUV5 (○ continuous
line). The calcium concentration for half maximal aggregation (EC50) and the number
of experiments performed are in Table 2.
Fig. 3. Changes in membrane ﬂuidity induced by AnxA2. Changes in membrane ﬂuidity expressed as ΔGP (GPAnxA2-LUVs - GPfree-LUVs). PS-LUVs at 23 and 37 °C in the presence of
500 μM calcium (a). PS-LUVs at 23 and 37 °C at pH 4.5 (b). PI2P-LUVs at 23 and 37 °C in the presence of 500 μM calcium (c). PI2P-LUVs at 23 and 37 °C at pH 4.5 (d). Bars are
the mean±Std. error from 2 to 8 experiments. *Pb0.05, **Pb0.01, ***Pb0.001.
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crease in membrane ﬂuidity. The state of a membrane can be quantita-
tively characterized by the ratiometric function GP (generalized
polarization) (see methods). Therefore protein-induced membrane
changes can be estimated by the ΔGP (GPﬁnal−GPinitial). A positive
ΔGP indicates a decrease in ﬂuidity and a negative ΔGP an increase
in ﬂuidity.
The ΔGP (GPAnxA2-Ca2+−LUVs minus GPCa2+−LUVs) was measured
for the ﬁve different PS-LUVs. As a control we used LUVs with a
small quantity of ligand phospholipid (2.5% of PI2P). With these
LUVs in the absence of presence of cholesterol, no membrane aggre-
gation was observed even at 1 mM free Ca2+, and laurdan spectra
were not modiﬁed in the presence of the protein and Ca2+. Several
spectra showing the AnxA2 effects in different conditions are illus-
trated in the supplementary ﬁgure S1 (additional ﬁle), and Fig. 3
shows the measured AnxA2-induced ΔGP.We used a calcium concen-
tration of 500 μM because in these conditions all membrane binding
sites will be occupied by the protein. Therefore, we were sure that
the differences observed were not due to differences in calcium de-
pendent protein binding efﬁciency (this is the same for H+ concen-
tration in the case of pH4.5 experiments). For the PS-LUVs in the
presence of calcium (pCa 3.3), we observed a small decrease in mem-
brane ﬂuidity after AnxA2 addition at two temperatures (Fig. 3a). The
PS-LUV4 (plasma membrane mimicking without cholesterol) showed
the stronger decrease in ﬂuidity with a ΔGP value of about 0.03. The
controls showed small ΔGP changes (from−0.004 to 0.003). Because
AnxA2 presents also a Ca2+-independent H+-dependent phospholipid
binding, we performed the same experiments at pH 4.5. Fig. 3b shows
variable small decrease in ﬂuidity after AnxA2 addition. However, with
the PS-LUV1 (rich in PS without cholesterol), the effect was stronger at
both temperatures (ΔGP values about 0.04). AnxA2 induced less effect
in PS-LUVs containing cholesterol compared to the cholesterol-free
membranes. In a second series of experiments, we studied theAnxA2 ef-
fect on PI2P-LUVs in the presence of calcium (pCa 3.3) and at pH 4.5. The
results in Fig. 3c show that AnxA2 induced a decrease in ﬂuidity of all
PI2P-LUVs tested. At 23 °C the tendencies of four PI2P-LUVswere similar
to those observedwith the PS-LUVs but they showed higherΔGP values.
At 37 °C, with the exception of PI2P-LUV5, the effect was stronger for
PI2P-LUVs compared to PS-LUVs with ΔGP values ranging from 0.04 to0.07 indicating that the protein reduces the ﬂuidity of PI2P-membranes
more than in PS-membranes. At pH 4.5 and 37 °C, AnxA2 also induced
high decrease in ﬂuidity on PI2P-LUV4 compared to PS-LUVs (Fig. 3d).
Overall, these results show that AnxA2-mediated reduction in ﬂuidity is
stronger in PI2P-LUVs than in PS-LUVs especially in the presence of
calcium.
To test whether AnxA2 was able to modify the ﬂuidity of biological
membranes we prepared Triton X-100 resistant membranes (DRMs)
from undifferentiated and differentiated (epithelial polarized) MDCK
cells. Fig. 4a shows that in epithelial polarized cells, AnxA2 is localized
on the lateral membranes where cell contacts are established and on
the apicalmembrane as previously described [42,43]. In undifferentiated
cells AnxA2 ismainly cytosolic but a fraction remains associatedwith the
plasma membrane (Fig. 4b). The DRMs were separated by ﬂotation in
twelve fractions that were characterized. AnxA2 and caveolin1 were
found in fractions 4 and 5 of differentiated cells (Fig. 4c). Therefore we
used these fractions for the next experiments.
The ﬂuorescent probe used to monitor the ﬂuidity changes of
DRMs was di-4-ANEPPDHQ. Like laurdan, this probe is sensitive to
the membrane ﬂuidity and the cholesterol contents. It is water solu-
ble and ﬂuoresces only when incorporated into the lipid bilayer.
AnxA2 alone did not induce ﬂuorescence indicating that the protein
does not associate to the probe (supplementary Fig. S2 of additional
ﬁle). Fig. 4d shows the di-4-ANEPPDHQ spectra of DRM fraction 5
from differentiated (D5) and undifferentiated (I5) MDCK cells indi-
cating that DRMs from differentiated cells are less ﬂuid (blue shifted)
than those from undifferentiated cells (red shifted). This difference,
also observed for fractions 4, is due to the fact that the plasma mem-
brane of differentiated cells and especially the apical membrane is
rich in cholesterol and sphingomyelin. The GPs were measured before
and after AnxA2 addition to DRMs in the presence of 500 μM free cal-
cium and the ΔGP was calculated. Fig. 5a shows that Ca2+ does not
change signiﬁcantly the spectra of the DRMs. The ΔGP values in
Fig. 5b, demonstrate that AnxA2 induces a decrease in ﬂuidity of the
DRMs at 23 and 37 °C. The effect was smaller for the DRMs from dif-
ferentiated MDCK cells (ΔGP values between 0.02 and 0.03) than for
DRMs from undifferentiated cells with ΔGP values about 0.04 at 37 °C
and 0.06–0.07 at 23 °C. The effect was reversible as shown by the
addition of EGTA which induces AnxA2 membrane dissociation
Fig. 4. Cellular distribution of annexin A2 and characterization of the DRM fractions of
differentiated and undifferentiated MDCK cells. AnxA2 labeling in confocal slices of dif-
ferentiated epithelial (a) and undifferentiated MDCK cells (b). AnxA2 (green), S100A10
(red) and E-cadherin (blue). Confocal images in the XY plane on top and in Z plane
(AnxA2 (green) and E-cadherin (red)) at bottom. Bars: 10 μm. (c); Western blots of
AnxA2 and Caveolin1 in discontinuous sucrose gradients from differentiated (D) and
undifferentiated (I) cells. DRMs are found in fractions 4 and 5. (d); Di-4-ANEPPDHQ
spectra of fractions 5 from undifferentiated (dark line), and differentiated cells (light
gray line). DRMs from differentiated cells are less ﬂuid (blue shifted) than those from
undifferentiated cells.
Fig. 5. Annexin A2 reduces the ﬂuidity of detergent resistant membranes (DRMs).
(a); representative di-4-ANEPPDHQ spectra of DRM fraction 4 from undifferentiated
cells (dotted line), after sequential addition of 500 μM free-Ca2+ (dashed line),
AnxA2 (continuous line, arrow), and addition of EGTA 1 mM to test the reversibility
of the AnxA2 effect (dash-dotted line). Spectra were obtained at 23 °C. (b); ΔGP after
AnxA2 addition on DRM fractions 4 and 5 from epithelial differentiated (D4, D5) and
undifferentiated (I4, I5) MDCK cells at 23 and 37 °C. Mean of two experiments in trip-
licate. Notice the stronger effect induced by AnxA2 on DRMs from undifferentiated
cells (I).
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duce the ﬂuidity of membranes from biological origin the effect
being stronger at low cholesterol content.
4. Discussion
The annexin speciﬁcity for different phospholipids has been studied
in several conditions [6,7,10]. Phospholipid preferences are not exclu-
sive of annexins and are shared by other domains such as the plekstrin
domain of evt-2 protein which prefers PS to PIs [44]. Herein, we show
that the Ca2+-sensitivity for annexin A2 mediated membrane bridging
does not correlate with the concentration of the anionic phospholipidinvolved in binding (PS or PI2P). However, some interesting tendencies
were observed (supplementary ﬁgure S3). First, the presence of choles-
terol results in a decrease in the calcium concentration necessary for
membrane bridging of PS-LUVs. This fact is consistentwith the previously
published enhancement of AnxA2 membrane binding by cholesterol
[16,17,22,23]. However, for the PI2P-containing membranes the Ca2+-
sensitivity enhancement by cholesterolwas not clear. The second tenden-
cywas that the PI2P-LUVs rich in PE showed lower calcium requirements.
These data demonstrate that the annexin A2-mediated membrane
bridging depends more on the organization of phospholipids (mem-
brane domains) than on the global concentration of a speciﬁc ligand
and that each ligand phospholipid has speciﬁc environmental condi-
tions for efﬁcient Ca2+-dependent binding of AnxA2. For example,
with PS-LUV1, 2 and 3 AnxA2 required lower calcium concentrations
compared to PI2P-LUVs, but AnxA2 required similar calcium concen-
tration for PS- and PI2P-LUV5. However, in most cases, we observed
higher calcium requirement for PI2P than for PS containing LUVs.
The strong negative charge of PI2P would require higher Ca2+ concen-
tration for charge titration (decrease in charge mediated repulsion) to
allowAnxA2bridging. These data suggest that the spontaneous distribu-
tion of membrane lipids create domains rich or poor in ligand phospho-
lipids allowing theprotein to bind at lowor high calciumconcentrations.
Considering the capacity of AnxA2 to change themembrane ﬂuidity,
we observed that the proteinwas able to reducemembraneﬂuidity. The
strength of this effect was also dependent on the lipid composition. In
the presence of calcium, PS-LUVs showed weak decrease in membrane
ﬂuidity after AnxA2 binding. PS-LUV4 which contains no cholesterol
and low PS content showed moderate effect (supplementary ﬁgure
S3). In the absence of calcium and atmild acidic pH, the decrease in ﬂu-
idity of the PS-LUVs without cholesterol was stronger than in the pres-
ence of calcium. Interestingly, the capacity of AnxA2 to reduce the
Fig. 6. Schematic representation of AnxA2 effects on membranes. In left part of (a) the membrane is composed of different lipids (geometric ﬁgures) distributed in different do-
mains. After AnxA2 (oval) binding, the ligand phospholipid associates strongly to the protein (gray circles). This interaction (right of a) provokes the redistribution of lipids
with the consequent creation of new domains with different properties. The zone of the membrane that is not in contact with the protein might be modiﬁed by the
protein-induced redistribution of lipids (box). (b) Illustrates the preferences of AnxA2 for the different phospholipids in the presence or the absence of calcium and the associated
effect on ﬂuidity. The Ca2+-independent action is schematized in gray, the Ca2+-dependent process in black. Phospholipids are abbreviated as in the text and cholesterol by CH.
Membrane ﬂuidity is schematized at the bottom. Strong reduction in membrane ﬂuidity is coded by the straight bars, ﬂuidity by rippled bars and moderate AnxA2 effect by
straight-rippled bars. See details in the text.
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was also enhanced in cholesterol-free PI2P-LUVs. This tendency was
also observed at acidic pH. However, contrary to the PS-LUVs, the effect
was stronger with calcium than at acidic pH demonstrating again
phospholipid-dependent behavior.
To test the AnxA2 effects on membranes from biological origin, we
prepared TX-100 resistant membrane fractions from differentiated
and undifferentiated cells. These fractions can be considered as DRMs
from different cell types. The differentiated MDCK cells present an api-
cal membrane rich in cholesterol and sphingolipids which are charac-
teristic of the raft-DRM domains and present higher order compared
to the basolateral membrane (see the MDCK lipidomic characterization
in [45]). The undifferentiated cells do not present this apicalmembrane.
Therefore itwas expected that theDRMs from these two cell typeswere
different. Those from differentiated cells are rich in cholesterol and thus
more rigid. The DRMs from undifferentiated cells have less cholesterol
and are more ﬂuid. The fact that DRMs can be of quite different compo-
sition was previously discussed in [46]. In spite of the fact that the
TX-100 treatment can induce the redistribution of cholesterol creating
membrane “domains” [47], the idea in this work was to test the effect
of Anx2 in two DRMs of different composition with different rigidity
and cholesterol content and containing natural lipid species and mem-
brane proteins. As shown by the ANNEPDHQ spectra, the differentiated
DRMs rich in apical membrane show higher rigidity due in part to their
high cholesterol content [41]. The results we observed with DRMs are
consistent with the results from LUVs indicating that Anx2 induction
of rigidity is stronger in ﬂuid membranes than in rigid membranes.
The presented data is also consistent with reports showing that some
annexins are able to redistribute phospholipids [9,11,12] and change
the membrane ﬂuidity [48] depending on the phospholipid composi-
tion [10,13].
The explanation for the AnxA2-mediated membrane ﬂuidity reduc-
tion must be based on the capacity of annexins to bind speciﬁc anionic
phospholipids. After phospholipid binding, the different afﬁnities be-
tween all the lipids may determine their redistribution. This redistribu-
tion will depend on two facts: 1) the creation of new spacing between
the anionic protein-bound phospholipid and 2) the change of the
head group charge interactions. In other words, the binding of fouranionic phospholipids to the four AnxA2 repeats, would change ﬁrst
the original distances between them restraining their movement, and
second, the charges on the head groups would be differently oriented
with the consequent change of repulsion–attraction forces between
the bound phospholipids and the unbound lipids. This spacing and
charge changes will allow lipid redistribution in different domains
(Fig. 6a). Considering that the overall lipid volume, the head group
size and the net charge of PI2P are higher than PS, it is expected that
AnxA2 bound to PS or PI2P will induce different effects on the mem-
brane lipid redistribution with the consequent differences in the phys-
icochemical properties of the membranes.
How do these data help to understand the role of lipids on
AnxA2 functions? Based on our results we suggest that in the cell,
the Ca2+ or H+ requirements for membrane binding and the func-
tions and effects of AnxA2 will be different depending on the target
membrane. In the absence of Ca2+ at low H+ concentration, AnxA2
would bind preferentially to PS-cholesterol-rich membranes and/
or PI2P-cholesterol-poor membranes with a strong effect on the
PI2P-membranes. This situation would be implicated for the
endosomal functions of annexin A2 in which the protein seems to
bind the membrane in a Ca2+-independent manner [17,23], but
also to the reported H+ dependent binding to the plasma mem-
brane [26]. In the presence of calcium, AnxA2 will be able to bind to
the PIP2-cholesterol-rich membranes and/or to the PS-cholesterol-
poor membranes with a strong decrease in ﬂuidity of membranes
poor in cholesterol and rich in PE. This situation would represent the
annexin A2 role in Ca2+-mediated processes such as the stimulated
exocytosis in endothelial and chromafﬁn cells [15,49,50] in which
AnxA2 was found to localize in PI2P-enriched exocytic domains [31].
Therefore, AnxA2 will induce speciﬁc effects for the reported functions
such as Ca2+-mediated secretion, endosomal regulation and plasma
membrane domains organization.
5. Conclusions
Thedata schematically represented in Fig. 6b (see also supplementary
ﬁgure S3), show that; 1) the PSmembranes require less calcium than the
PI2P membranes for AnxA2 membrane bridging. 2) Cholesterol reduces
2899F. Illien et al. / Biochimica et Biophysica Acta 1818 (2012) 2892–2900the calcium requirements for AnxA2 on PS membranes. 3) AnxA2 de-
creases the ﬂuidity of PI2P membranes more than the PS membranes.
4) AnxA2 diminishes the ﬂuidity of the PS membranes more in the pres-
ence of H+ than in the presence of Ca2+, but the effect on PI2P
membranes is stronger in the presence of Ca2+ than at acidic pH,
and 5). Cholesterol reduces AnxA2 capacity to reduce membrane ﬂuid-
ity. These data shed light on the molecular mechanisms necessary to
understand the speciﬁc effects of annexin A2 in membranes rich in
PI2P, PS or cholesterol and also in membrane domains regulation
[14,15,27–29]. However, for the ﬁne understanding of the AnxA2 func-
tions on membrane regulation, the future lipidomic analysis of cellular
AnxA2 target membranes is the next step to take.
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